Melih Cem Börüban

Tamoxifen Inhibits Cytochrome P450 2C9 Activity in Breast Cancer Patients

Melih Cem Börüban, Ümit Yaşar, Melih O. Babaoğlu et al. · Journal of Chemotherapy · 2006 · 30 citations

Medicine, Pharmacokinetics, Pharmacology +11

Prognostic Impact of Neutrophil/Lymphocyte Ratio, Platelet Count, CRP, and Albumin Levels in Metastatic Colorectal Cancer Patients Treated with FOLFIRI-Bevacizumab

Mehmet Artaç, Mükremın Uysal, Mustafa Karaağaç et al. · Journal of Gastrointestinal Cancer · 2016 · 30 citations

Medicine, Hematology, Oncology +17

Chemotherapy-induced Hepatitis B virus reactivation in HbsAg positive cancer patients: a single center experience

Orhan Önder Eren, Mehmet Artaç, Melih Cem Börüban et al. · Medical Oncology · 2008 · 26 citations

Medicine, Oncology, Pharmacotherapy +13

Serum leptin level and waist-to-hip ratio (WHR) predict the overall survival of metastatic breast cancer (MBC) patients treated with aromatase inhibitors (AIs)

Mehmet Artaç, Hakan Bozcuk, Aysel Kıyıcı et al. · Breast Cancer · 2011 · 12 citations

Medicine, Oncology, Pharmacology +17

Treatment modalities in primary gastric lymphoma: effect of rituximab and surgical treatment. A study by the Anatolian Society of Medical Oncology

Mehmet Küçüköner, Şener Cihan, Ümmügül Üyetürk et al. · Współczesna Onkologia · 2014 · 11 citations · Full text

Medicine, Oncology, Surgery +14